Diana Grove-Laugesen1, Sofie Malmstroem2, Eva Ebbehoj2, Anne Lene Riis3, Torquil Watt4, Klavs Würgler Hansen5, Lars Rejnmark2. 1. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, 8200, Aarhus N, Denmark. dianagrove@clin.au.dk. 2. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, 8200, Aarhus N, Denmark. 3. Medical Department, Regional Hospital Horsens, Sundvej 30, 8700, Horsens, Denmark. 4. Department of Internal Medicine, Gentofte and Herlev Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark. 5. Medical Department, Silkeborg Regional Hospital, Falkevej 3, 8600, Silkeborg, Denmark.
Abstract
PURPOSE:Risk of cardiovascular disease (CVD) is increased in Graves' disease (GD). CVD is predicted by increased pulse wave velocity (PWV) and blood pressure (BP). GD and these risk factors are all associated with lower levels of vitamin D. We aimed to assess the effect of supplemental vitamin D on PWV and BP in GD. METHODS: In a double-blinded trial, newly diagnosed GD patients were randomized to vitamin D3 70 µg/day (n = 44) or placebo (n = 42) as add-on to anti-thyroid medication. At baseline, 3 and 9 months PWV, BP and wave analysis were performed in office and 24 h setting. Between-group differences in change at 9 months were analyzed using linear mixed modelling. In subanalysis, effect of intervention in regard to baseline vitamin D insufficiency (25(OH)D < 50 nmol/L) was investigated. (The DAGMAR study, clinicaltrials.gov ID NCT02384668). RESULTS:PWV was unaffected by intervention in main analysis. However in the subanalysis, comparing the response to intervention in the vitamin D insufficient (n = 28) and the vitamin D replete patients, supplemental vitamin D induced a significant decrease in office PWV of 1.2 (95% CI: -2.3; -0.1) m/s compared to placebo. Of notice, baseline PWV was non-significantly higher among the vitamin D insufficient as compared to the replete participants. In response to vitamin D, office central systolic BP (-3.9 (95% CI: -7.5; -0.3) and brachial mean BP (-3.3 (95% CI: -6.5; -0.3) declined whereas 24 h measurements were unaffected. CONCLUSIONS:High-dose vitamin D supplementation did not affect PWV. We observed significant reduction in office but not 24 h BP. Subanalysis showed a clinically relevant PWV reduction among vitamin D insufficient participants, although regression towards the mean might contribute to findings. Further studies on supplemental vitamin D in GD should focus on patients with vitamin D insufficiency.
RCT Entities:
PURPOSE: Risk of cardiovascular disease (CVD) is increased in Graves' disease (GD). CVD is predicted by increased pulse wave velocity (PWV) and blood pressure (BP). GD and these risk factors are all associated with lower levels of vitamin D. We aimed to assess the effect of supplemental vitamin D on PWV and BP in GD. METHODS: In a double-blinded trial, newly diagnosed GDpatients were randomized to vitamin D3 70 µg/day (n = 44) or placebo (n = 42) as add-on to anti-thyroid medication. At baseline, 3 and 9 months PWV, BP and wave analysis were performed in office and 24 h setting. Between-group differences in change at 9 months were analyzed using linear mixed modelling. In subanalysis, effect of intervention in regard to baseline vitamin Dinsufficiency (25(OH)D < 50 nmol/L) was investigated. (The DAGMAR study, clinicaltrials.gov ID NCT02384668). RESULTS: PWV was unaffected by intervention in main analysis. However in the subanalysis, comparing the response to intervention in the vitamin D insufficient (n = 28) and the vitamin D replete patients, supplemental vitamin D induced a significant decrease in office PWV of 1.2 (95% CI: -2.3; -0.1) m/s compared to placebo. Of notice, baseline PWV was non-significantly higher among the vitamin D insufficient as compared to the replete participants. In response to vitamin D, office central systolic BP (-3.9 (95% CI: -7.5; -0.3) and brachial mean BP (-3.3 (95% CI: -6.5; -0.3) declined whereas 24 h measurements were unaffected. CONCLUSIONS: High-dose vitamin D supplementation did not affect PWV. We observed significant reduction in office but not 24 h BP. Subanalysis showed a clinically relevant PWV reduction among vitamin D insufficient participants, although regression towards the mean might contribute to findings. Further studies on supplemental vitamin D in GD should focus on patients with vitamin Dinsufficiency.
Authors: M H Hwang; J K Yoo; H K Kim; C L Hwang; K Mackay; O Hemstreet; W W Nichols; D D Christou Journal: J Hum Hypertens Date: 2014-01-16 Impact factor: 3.012
Authors: Yanbin Dong; Inger S Stallmann-Jorgensen; Norman K Pollock; Ryan A Harris; Daniel Keeton; Ying Huang; Ke Li; Reda Bassali; De-huang Guo; Jeffrey Thomas; Gary L Pierce; Jennifer White; Michael F Holick; Haidong Zhu Journal: J Clin Endocrinol Metab Date: 2010-07-21 Impact factor: 5.958
Authors: Yan Chun Li; Guilin Qiao; Milan Uskokovic; Wei Xiang; Wei Zheng; Juan Kong Journal: J Steroid Biochem Mol Biol Date: 2004-05 Impact factor: 4.292
Authors: Thomas Larsen; Frank H Mose; Jesper N Bech; Annebirthe Bo Hansen; Erling B Pedersen Journal: Am J Hypertens Date: 2012-08-02 Impact factor: 2.689
Authors: John D Sluyter; Carlos A Camargo; Alistair W Stewart; Debbie Waayer; Carlene M M Lawes; Les Toop; Kay-Tee Khaw; Simon A McG Thom; Bernhard Hametner; Siegfried Wassertheurer; Kim H Parker; Alun D Hughes; Robert Scragg Journal: J Am Heart Assoc Date: 2017-10-24 Impact factor: 5.501
Authors: Louise A Beveridge; Faisel Khan; Allan D Struthers; Jane Armitage; Ilaria Barchetta; Iain Bressendorff; Maria Gisella Cavallo; Robert Clarke; Rinkoo Dalan; Gavin Dreyer; Adam D Gepner; Nita G Forouhi; Ryan A Harris; Graham A Hitman; Thomas Larsen; Rajesh Khadgawat; Peter Marckmann; Frank H Mose; Stefan Pilz; Alexandra Scholze; Marina Shargorodsky; Seth I Sokol; Hans Stricker; Carmine Zoccali; Miles D Witham Journal: J Am Heart Assoc Date: 2018-05-30 Impact factor: 5.501
Authors: Gavin Dreyer; Arthur T Tucker; Steven M Harwood; Rupert M Pearse; Martin J Raftery; Muhammad M Yaqoob Journal: PLoS One Date: 2014-07-09 Impact factor: 3.240
Authors: Thor Aspelund; Martin R Grübler; Albert V Smith; Elias F Gudmundsson; Martin Keppel; Mary Frances Cotch; Tamara B Harris; Rolf Jorde; Guri Grimnes; Ragnar Joakimsen; Henrik Schirmer; Tom Wilsgaard; Ellisiv B Mathiesen; Inger Njølstad; Maja-Lisa Løchen; Winfried März; Marcus E Kleber; Andreas Tomaschitz; Diana Grove-Laugesen; Lars Rejnmark; Karin M A Swart; Ingeborg A Brouwer; Paul Lips; Natasja M van Schoor; Christopher T Sempos; Ramón A Durazo-Arvizu; Zuzana Škrabáková; Kirsten G Dowling; Kevin D Cashman; Mairead Kiely; Stefan Pilz; Vilmundur Gudnason; Gudny Eiriksdottir Journal: Nutrients Date: 2019-01-02 Impact factor: 5.717